Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: Dr Eisenstein and colleagues1 assessed the association between long-term clopidogrel use and clinical outcomes after drug-eluting stent (DES) implantation. The authors suggested that all patients with DES should continue to take clopidogrel for at least 12 months after intervention and possibly indefinitely. However, some methodological issues need to be considered.
Alfonso F. Clopidogrel and Long-term Outcomes After Drug-Eluting Stent Implantation. JAMA. 2007;297(16):1769-1771. doi:10.1001/jama.297.16.1769-a